Talphera (TLPH) Long-Term Deferred Tax (2017 - 2018)

Talphera (TLPH) recorded quarterly Long-Term Deferred Tax of $351000.0 in Q3 2018, little changed quarter-over-quarter from $351000.0 in Q2 2018.

Talphera (TLPH) Long-Term Deferred Tax (2017 - 2018) Analysis & Trends

Talphera's Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $351000.0 for Q3 2018.

In Q3 2018, Long-Term Deferred Tax changed N/A year-over-year to $351000.0; the TTM figure through Sep 2018 stood at $351000.0 (changed N/A YoY), while the FY2017 annual figure was $703000.0, changed N/A from the prior year.
Long-Term Deferred Tax was $351000.0 for Q3 2018 at Talphera, roughly flat from $351000.0 in the prior quarter.
In the past five years, Long-Term Deferred Tax ranged from a high of $703000.0 in Q4 2017 to a low of $351000.0 in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	Talphera	56.42 Mn	56.42 Mn	-

Download Data